14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
COCH vs ISRG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Intuitive Surgical Inc. (ISRG) is the stronger overall head-to-head candidate over Envoy Medical, Inc. (COCH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). COCH carries a Unified Composite Score of 35.1/100 (SELL) at $6.70 (N/M Forward P/E, -10261.0% operating margin), whereas ISRG carries 43.8/100 (HOLD) at $399.05 (32.0x Forward P/E, 31.7% operating margin).
Growth vs. Quality Trade-Off: ISRG earns the overall head-to-head edge with a stronger Unified Composite Score (43.8/100 HOLD vs. COCH 35.1/100 SELL) and 0.81β · 44% Vol risk profile, whereas COCH leads top-line expansion (+57.1% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Competes within the Medical Devices value chain with $51.9M market capitalization and -10261.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
ISRG Moat ProfileHigh-Margin Pricing Power Moat
Medical Instruments & Supplies Operator
Competes within the Medical Instruments & Supplies value chain with $141.2B market capitalization and 31.7% operating margin.
OpEx & R&D Reinvestment34.9% of Rev ($4.04B)
90D Engineering Disclosures0 Published · Robot Manipulation
Investor FAQ COCH vs ISRG Key Questions & Quantitative Answers
As of Nov 20, 2026, Intuitive Surgical Inc. (ISRG) is the stronger overall head-to-head candidate over Envoy Medical, Inc. (COCH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). COCH carries a Unified Composite Score of 35.1/100 (SELL) at $6.70 (N/M Forward P/E, -10261.0% operating margin), whereas ISRG carries 43.8/100 (HOLD) at $399.05 (32.0x Forward P/E, 31.7% operating margin). Growth vs. Quality Trade-Off: ISRG earns the overall head-to-head edge with a stronger Unified Composite Score (43.8/100 HOLD vs. COCH 35.1/100 SELL) and 0.81β · 44% Vol risk profile, whereas COCH leads top-line expansion (+57.1% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
COCH leads the Growth & Scale pillar: COCH posts +57.1% YoY revenue growth and +0.0% YoY earnings growth on $231,000 TTM revenue (N/A gross margin, -10261.0% operating margin), compared with ISRG at +21.7% YoY revenue growth and -23.6% YoY earnings growth on $11.6B TTM revenue (66.6% gross margin, 31.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), COCH cumulative revenue shifted N/A while ISRG shifted +170.4%. In operating R&D and SG&A reinvestment, COCH deploys N/A (0 90-day corporate R&D disclosures) versus 34.9% of Rev ($4.04B) (0 disclosures) for ISRG.
ISRG screens cheaper on headline valuation multiples. COCH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 119.2x EV/Revenue (unreported FCF margin), whereas ISRG trades at 32.0x Forward P/E, 49.2x Trailing P/E, 1.90x PEG, and 12.2x EV/Revenue (31.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against COCH (0.0% ROE) versus ISRG (17.9% ROE) capital efficiency.
In options market volatility and institutional positioning, COCH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.94β · 3352% Vol realized risk). By comparison, ISRG carries 132.6% implied volatility (69th %ile, Elevated (60th–80th %ile)), a 0.84x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.81β · 44% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.